996
Views
0
CrossRef citations to date
0
Altmetric
Hemodialysis and Peritoneal Dialysis

Cathepsin G promotes arteriovenous fistula maturation by positively regulating the MMP2/MMP9 pathway

, , , , , , & show all
Article: 2316269 | Received 18 Oct 2023, Accepted 04 Feb 2024, Published online: 16 Feb 2024

References

  • Lok CE, Huber TS, Lee T, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(2):1–15. doi: 10.1053/j.ajkd.2019.12.001.
  • Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: upper-arm native arteriovenous fistula. Am J Kidney Dis. 2002;39(1):92–101. doi: 10.1053/ajkd.2002.29886.
  • Iyem H. Early follow-up results of arteriovenous fistulae created for hemodialysis. Vasc Health Risk Manag. 2011;7:321–325. doi: 10.2147/VHRM.S14277.
  • Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299(18):2164–2171. doi: 10.1001/jama.299.18.2164.
  • Robbin ML, Chamberlain NE, Lockhart ME, et al. Hemodialysis arteriovenous fistula maturity: US evaluation. Radiology. 2002;225(1):59–64. doi: 10.1148/radiol.2251011367.
  • Asif A, Cherla G, Merrill D, et al. Conversion of tunneled hemodialysis Catheter-Consigned patients to arteriovenous fistula. Kidney Int. 2005;67(6):2399–2406. doi: 10.1111/j.1523-1755.2005.00347.x.
  • Laboyrie SL, de Vries MR, de Jong A, et al. Von Willebrand factor: a central regulator of arteriovenous fistula maturation through smooth muscle cell proliferation and outward remodeling. J Am Heart Assoc. 2022;11(16):e024581. doi: 10.1161/JAHA.121.024581.
  • Siddiqui MA, Ashraff S, Santos D, et al. An overview of AVF maturation and endothelial dysfunction in an advanced renal failure. Ren Replace Ther. 2017;3(1):42. doi: 10.1186/s41100-017-0123-x.
  • Asif A, Roy-Chaudhury P, Beathard GA. Early arteriovenous fistula failure: a logical proposal for when and how to intervene. Clin J Am Soc Nephrol. 2006;1(2):332–339. doi: 10.2215/CJN.00850805.
  • Martinez L, Duque JC, Tabbara M, et al. Fibrotic venous remodeling and nonmaturation of arteriovenous fistulas. J Am Soc Nephrol. 2018;29(3):1030–1040. doi: 10.1681/ASN.2017050559.
  • Rothuizen TC, Wong C, Quax PHA, et al. Arteriovenous access failure: more than just intimal hyperplasia? Nephrol Dial Transplant. 2013;28(5):1085–1092. doi: 10.1093/ndt/gft068.
  • Allon M, Litovsky S, Young CJ, et al. Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation. Am J Kidney Dis. 2011;58(3):437–443. doi: 10.1053/j.ajkd.2011.04.018.
  • Martinez L, Tabbara M, Duque JC, et al. Transcriptomics of human arteriovenous fistula failure: genes associated with nonmaturation. Am J Kidney Dis. 2019;74(1):73–81. doi: 10.1053/j.ajkd.2018.12.035.
  • Martinez L, Rojas MG, Tabbara M, et al. The transcriptomics of the human vein transformation after arteriovenous fistula anastomosis uncovers Layer-Specific remodeling and hallmarks of maturation failure. Kidney Int Rep. 2023;8(4):837–850. doi: 10.1016/j.ekir.2023.01.008.
  • Song A, Yin X, Gao P, et al. Inhibition of MAD2B alleviates venous neointimal formation by suppressing VSMCs proliferation and migration. Faseb J. 2021;35(11):e21959. doi: 10.1096/fj.202100584RR.
  • Murphy G, Bretz U, Baggiolini M, et al. The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes. Biochem J. 1980;192(2):517–525. doi: 10.1042/bj1920517.
  • Saunders WB, Bayless KJ, Davis GE. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci. 2005;118(Pt 10):2325–2340. doi: 10.1242/jcs.02360.
  • Knäuper V, Krämer S, Reinke H, et al. Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-Terminal sequence determination of the proenzyme and various proteolytically activated forms. Eur J Biochem. 1990;189(2):295–300. doi: 10.1111/j.1432-1033.1990.tb15489.x.
  • Capodici C, Muthukumaran G, Amoruso MA, et al. Activation of neutrophil collagenase by cathepsin G. Inflammation. 1989;13(3):245–258. doi: 10.1007/BF00914392.
  • Woodside KJ, Bell S, Mukhopadhyay P, et al. Arteriovenous fistula maturation in prevalent hemodialysis patients in the United States: a national study. Am J Kidney Dis. 2018;71(6):793–801. doi: 10.1053/j.ajkd.2017.11.020.
  • Huber TS, Berceli SA, Scali ST, et al. Arteriovenous fistula maturation, functional patency, and intervention rates. JAMA Surg. 2021;156(12):1111–1118. doi: 10.1001/jamasurg.2021.4527.
  • Gorecka J, Fereydooni A, Gonzalez L, et al. Molecular targets for improving arteriovenous fistula maturation and patency. Vasc Investig Ther. 2019;2(2):33–41. doi: 10.4103/VIT.VIT_9_19.
  • Kuwahara G, Hashimoto T, Tsuneki M, et al. CD44 promotes inflammation and extracellular matrix production during arteriovenous fistula maturation. Arterioscler Thromb Vasc Biol. 2017;37(6):1147–1156. doi: 10.1161/ATVBAHA.117.309385.
  • Liu Q, Ba YG. Progress in pathologic mechanism of autogenous arteriovenous fistula dysfunction. ACM. 2022;12(06):5968–5973.
  • Starkey PM, Barrett AJ. Human cathepsin G. Catalytic and immunological properties. Biochem J. 1976;155(2):273–278. doi: 10.1042/bj1550273.
  • Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54(1):1.30.1–1.30.33. doi: 10.1002/cpbi.5.
  • Xiong L, Cao J, Qiu Y, et al. Exploring the mechanism of aspirin in the treatment of Kawasaki disease based on molecular docking and molecular dynamics. Evid Based Complement Alternat Med. 2022;2022:9828518–9828511. doi: 10.1155/2022/9828518.
  • Jin W, Wu K, Li YZ, et al. AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia. Oncogene. 2013;32(15):1978–1987. doi: 10.1038/onc.2012.204.
  • Chan S, Wang X, Wang Z, et al. CTSG suppresses colorectal cancer progression through negative regulation of Akt/MTOR/Bcl2 signaling pathway. Int J Biol Sci. 2023;19(7):2220–2233. doi: 10.7150/ijbs.82000.
  • Roweth HG, Malloy MW, Goreczny GJ, et al. Pro-inflammatory megakaryocyte gene expression in murine models of breast cancer. Sci Adv. 2022;8(41):eabo5224. doi: 10.1126/sciadv.abo5224.
  • Aghdassi AA, John DS, Sendler M, et al. Absence of the neutrophil serine protease cathepsin G decreases neutrophil granulocyte infiltration but does not change the severity of acute pancreatitis. Sci Rep. 2019;9(1):16774. doi: 10.1038/s41598-019-53293-0.
  • Pham CTN. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol. 2006;6(7):541–550. doi: 10.1038/nri1841.
  • Son ED, Kim H, Choi H, et al. Cathepsin G increases MMP expression in normal human fibroblasts through fibronectin fragmentation, and induces the conversion of ProMMP-1 to active MMP-1. J Dermatol Sci. 2009;53(2):150–152. doi: 10.1016/j.jdermsci.2008.08.006.
  • Dwivedi AJ, Roy-Chaudhury P, Peden EK, et al. Application of human type I pancreatic elastase (PRT-201) to the venous anastomosis of arteriovenous grafts in patients with chronic kidney disease. J Vasc Access. 2014;15(5):376–384. doi: 10.5301/jva.5000235.
  • Vascular access for dialysis 1. NDT. 2007;22(6):vi149–vi158.
  • Cui J, Kessinger CW, Jhajj HS, et al. Atorvastatin reduces in vivo fibrin deposition and macrophage accumulation, and improves primary patency duration and maturation of murine arteriovenous fistula. J Am Soc Nephrol. 2020;31(5):931–945. doi: 10.1681/ASN.2019060612.
  • Chan CY, Chen YS, Ma MC, et al. Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats. J Vasc Surg. 2007;45(4):804–811. doi: 10.1016/j.jvs.2006.12.063.
  • Tirelli G, Nicastro L, Gatto A, et al. Stretching stenoses of the external auditory canal: a report of four cases and brief review of the literature. Acta Otorhinolaryngol Ital. 2015;35(1):34–38.